Literature DB >> 11297541

Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin.

Y P Han1, T L Tuan, M Hughes, H Wu, W L Garner.   

Abstract

Both cytokines and matrix metalloproteinases (MMPs) are active during physiologic and pathologic processes such as cancer metastasis and wound repair. We have systematically studied cytokine-mediated MMP regulation. Cytokine-mediated proteinase induction and activation were initially investigated in organ-cultured human skin followed by determination of underlying cellular and molecular mechanisms using isolated skin cells. In this report we demonstrate that tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta (TGF-beta) synergistically induce pro-MMP-9 in human skin as well as isolated dermal fibroblasts and epidermal keratinocytes. Furthermore, TNF-alpha promotes proteolytic activation of pro-MMP-9 by conversion of the 92-kDa pro-MMP-9 to the 82-kDa active enzyme. This activation occurred only in skin organ culture and not by either isolated fibroblasts or keratinocyte, although the pro-MMP-9 activation could be measured in a cell-free system derived from TNF-alpha-activated skin. The cytokine-mediated induction of pro-MMP-9 in dermal fibroblasts was evident by increased mRNA. At the transcription level, we examined the cytokine-mediated transactivation of the 5'-region promoter of the human MMP-9 in dermal fibroblasts. The results demonstrated that TNF-alpha and TGF-beta could independently stimulate the 5'-flanking 670-base pair promoter. A TGF-beta-response element (-474) and an NF-kappaB-binding site (-601) were identified to be the cis-elements for TGF-beta or TNF-alpha activation, respectively. Taken together, these findings suggest a specific mechanism whereby multiple cytokines can regulate MMP-9 expression/activation in the cells of human skin. These results imply roles for these cytokines in the regulation of MMP-9 in physiologic and pathologic tissue remodeling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297541      PMCID: PMC2651823          DOI: 10.1074/jbc.M010839200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.

Authors:  A Janowska-Wieczorek; L A Marquez; A Matsuzaki; H R Hashmi; L M Larratt; L M Boshkov; A R Turner; M C Zhang; D R Edwards; A E Kossakowska
Journal:  Br J Haematol       Date:  1999-05       Impact factor: 6.998

2.  Identification of a transforming growth factor-beta1/bone morphogenetic protein 4 (TGF-beta1/BMP4) response element within the mouse tissue transglutaminase gene promoter.

Authors:  S J Ritter; P J Davies
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

3.  Cooperation between SMAD and NF-kappaB in growth factor regulated type VII collagen gene expression.

Authors:  A Kon; L Vindevoghel; D J Kouba; Y Fujimura; J Uitto; A Mauviel
Journal:  Oncogene       Date:  1999-03-11       Impact factor: 9.867

4.  Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice.

Authors:  H R Lijnen; J Silence; B Van Hoef; D Collen
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

5.  Tumor necrosis factor mediates impaired wound healing in chronic abdominal sepsis.

Authors:  R Cooney; J Iocono; G Maish; J S Smith; P Ehrlich
Journal:  J Trauma       Date:  1997-03

6.  Gelatinase activity in keloids and hypertrophic scars.

Authors:  A N Neely; C E Clendening; J Gardner; D G Greenhalgh; G D Warden
Journal:  Wound Repair Regen       Date:  1999 May-Jun       Impact factor: 3.617

7.  Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing.

Authors:  A B Wysocki; A O Kusakabe; S Chang; T L Tuan
Journal:  Wound Repair Regen       Date:  1999 May-Jun       Impact factor: 3.617

8.  Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9.

Authors:  J F Tarlton; C J Vickery; D J Leaper; A J Bailey
Journal:  Br J Dermatol       Date:  1997-10       Impact factor: 9.302

9.  Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines.

Authors:  I Sehgal; T C Thompson
Journal:  Mol Biol Cell       Date:  1999-02       Impact factor: 4.138

10.  Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancer.

Authors:  Z S Zeng; J G Guillem
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

View more
  49 in total

1.  Epigenetic repression of matrix metalloproteinases in myofibroblastic hepatic stellate cells through histone deacetylases 4: implication in tissue fibrosis.

Authors:  Lan Qin; Yuan-Ping Han
Journal:  Am J Pathol       Date:  2010-09-16       Impact factor: 4.307

2.  Clinical and immunohistochemical characteristics of mucoceles.

Authors:  Eun Lee; Sang Hyun Cho; Chul Jong Park
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

Review 3.  Matrix metalloproteinases, the pros and cons, in liver fibrosis.

Authors:  Yuan-Ping Han
Journal:  J Gastroenterol Hepatol       Date:  2006-10       Impact factor: 4.029

Review 4.  Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Treat Respir Med       Date:  2006

5.  Curcumin accelerates cutaneous wound healing via multiple biological actions: The involvement of TNF-α, MMP-9, α-SMA, and collagen.

Authors:  Yu-Hsiu Yen; Chi-Ming Pu; Chen-Wei Liu; Ya-Chun Chen; Yu-Chen Chen; Chan-Jung Liang; Jung-Hsien Hsieh; Hui-Fu Huang; Yuh-Lien Chen
Journal:  Int Wound J       Date:  2018-04-16       Impact factor: 3.315

6.  Interleukin-1alpha-induced proteolytic activation of metalloproteinase-9 by human skin.

Authors:  Yuan-Ping Han; Susan Downey; Warren L Garner
Journal:  Surgery       Date:  2005-11       Impact factor: 3.982

Review 7.  The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases.

Authors:  A Rietz; Jp Spiers
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

8.  Matrix metalloproteinase-9 delays wound healing in a murine wound model.

Authors:  Matthew J Reiss; Yan-Ping Han; Edwin Garcia; Mytien Goldberg; Hong Yu; Warren L Garner
Journal:  Surgery       Date:  2009-12-11       Impact factor: 3.982

9.  Endothelial cells enhance prostate cancer metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals.

Authors:  Xiaohai Wang; Soo Ok Lee; Shujie Xia; Qi Jiang; Jie Luo; Lei Li; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Cancer Ther       Date:  2013-03-27       Impact factor: 6.261

10.  Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts.

Authors:  Laurence Goffin; Queralt Seguin-Estévez; Montserrat Alvarez; Walter Reith; Carlo Chizzolini
Journal:  Arthritis Res Ther       Date:  2010-04-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.